Australia's Rhythm Biosciences at nearly 6-month high on multi-year supply agreement
ReutersFeb 3, 2026 1:33 AM
Shares of Rhythm Biosciences RHY.AX rise as much as 33.3% to A$0.20, their highest level since August 6, 2025
The medical diagnostics tech firm secures a multi-year commercial supply agreement executed with U.S.-based Quansys Biosciences for ColoSTAT reagent kit manufacturing
Agreement provides scalable manufacturing capacity to support ColoSTAT Access Program and commercial rollout, adds co
About 1.5 million shares change hands, 2.3x the 30-day average
YTD, stock up 37% year, including the day's move
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Alibaba Share Price Projections: What Will Happen With Alibaba?
TradingKey - As we move toward the end of 2025 and prepare for 2030, Alibaba group (BABA) is truly at the beginning of a brand new growth trajectory.TradingKey
2 hours ago
Ripple Market Analysis: XRP Resilience Challenged as Institutional Infrastructure and Strategic Partnerships Pivot Towards 2030
TradingKey - The digital asset landscape is navigating a period of heightened volatility as we move through the final quarters of 2025 and into early 2026.TradingKey
15 hours ago
Google Earnings Preview: It’s a Buy on Strong Projected Cloud Business
Google will release its fourth-quarter earnings report after the market close on February 4, ET. Bloomberg analysts expect Q4 revenue to increase by 16% year-over-year to $95.08 billion. Adjusted net income is projected to grow 19% year-over-year to $38.55 billion, while GAAP earnings per share (EPSTradingKey
17 hours ago
USD Dollar Trend Forecast: Dollar Index Falls Below 97.0 to 4-Year Low, Will the Dollar Continue To Fall or Bottom Out in 2026?
TradingKey - In January 2026, the US Dollar Index continued its downward trend from 2025, officially breaking below the key 97.0 level and reaching a low of 95.5, marking a nearly four-year low since February 2022.TradingKey
Fri, Jan 30
